Francoise Mazingue

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study.

Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study.

Journal: Frontiers in pediatrics

Published: July 17, 2023

Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study.

Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study.

Journal: European journal of cancer care

Published: July 04, 2022

CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951.

CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Published: August 30, 2020

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.

Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients.

Journal: The journal of allergy and clinical immunology. In practice

Published: July 29, 2020

Long-term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized study.

Long-term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized study.

Journal: British journal of haematology

Published: July 05, 2019

Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.

Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor.

Journal: The Journal of infection

Published: April 27, 2019

Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL).

Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL).

Journal: British journal of haematology

Published: February 15, 2019

Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.

Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.

Journal: BMC pharmacology & toxicology

Published: September 04, 2018

Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency.

Intestinal dysbiosis in inflammatory bowel disease associated with primary immunodeficiency.

Journal: The Journal of allergy and clinical immunology

Published: June 23, 2018

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.

Journal: British journal of haematology

Published: May 16, 2018

Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.

Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.

Journal: Blood

Published: December 06, 2017

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.

Journal: Leukemia

Published: October 25, 2017

Showing 1-12 of 28

Last Updated: 09/26/2026